Author:
Liang Dong,Ma Jing,Wei Bo
Abstract
AbstractTo investigate the effect of simulated weightlessness on the pharmacokinetics of orally administered moxifloxacin and the antacid Maalox or the antidiarrheal Pepto-Bismol using a tail-suspended (TS) rat model of microgravity. Fasted control and TS, jugular-vein-cannulated, male Sprague-Dawley rats received either a single 5 mg/kg intravenous dose or a single 10 mg/kg oral dose of moxifloxacin alone or with a 0.625 mL/kg oral dose of Maalox or a 1.43 mL/kg oral dose of Pepto-Bismol. Plasma concentrations of moxifloxacin were measured by HPLC. Pharmacokinetic data were analyzed using WinNonlin. Simulated weightlessness had no effect on moxifloxacin disposition after intravenous administration but significantly decreased the extent of moxifloxacin oral absorption. The coadministration of moxifloxacin with Maalox to either control or TS rats caused significant reductions in the rate and extent of moxifloxacin absorption. In contrast, the coadministration of moxifloxacin with Pepto-Bismol to TS rats had no significant effect on either the rate or the extent of moxifloxacin absorption. These interactions showed dose staggering when oral administrations of Pepto-Bismol and moxifloxacin were separated by 60 min in control rats but not in TS rats. Dose staggering was more apparent after the coadministration of Maalox and moxifloxacin in TS rats.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Eyal, S. & Derendorf, H. Medications in space: in search of a pharmacologist’s guide to the galaxy. Pharm. Res. 36, 148 (2019).
2. Putcha, L., Berens, K. L., Marshburn, T. H., Ortega, H. J. & Billica, R. D. Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat. Space Environ. Med. 70, 705–708 (1999).
3. Wotring, V. E. Medication use by U.S. crewmembers on the international space station. FASEB J. 29, 4417–4423 (2015).
4. Li, M. et al. Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE exposure during spaceflight. PLoS ONE 10, e0120126 (2015).
5. Mermel, L. A. Infection prevention and control during prolonged human space travel. Clin. Infect. Dis. 56, 123–130 (2013).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献